Related Experiment Video
Updated: Jun 15, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Adaptive radiotherapy for lung cancer
Jan-Jakob Sonke1, José Belderbos
1Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. janjakob@nki.ni
Seminars in Radiation Oncology
|March 12, 2010
Summary
Adaptive radiation therapy (RT) improves lung cancer treatment by using advanced imaging to precisely track tumor motion and anatomical changes. This allows for more accurate dose delivery, reducing side effects and improving patient survival.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment
Background:
- Lung cancer radiation therapy (RT) faces geometrical uncertainties from respiratory motion and anatomical changes.
- Current safety margins limit dose escalation and treatment efficacy.
- Four-dimensional (4D) RT planning can improve initial treatment quality.
Purpose of the Study:
- To explore the potential of adaptive RT in improving lung cancer treatment accuracy.
- To reduce radiation exposure to healthy organs at risk.
- To facilitate safe dose escalation for better treatment outcomes.
Main Methods:
- Incorporating pretreatment patient-specific respiratory motion data into 4D inverse planning.
- Utilizing repetitive imaging during treatment to quantify geometrical variations (intrafraction, interfraction, progressive).
- Employing patient-specific parameters to drive adaptive plan modifications.
Main Results:
- Adaptive RT corrects for systematic errors and incorporates random errors in treatment planning.
- Repetitive imaging provides crucial data for real-time treatment adjustments.
- Patient-specific data enables precise correction of geometrical variations.
Conclusions:
- Adaptive RT significantly enhances the accuracy of lung cancer radiation therapy.
- Reduced organ-at-risk exposure and improved local control are key benefits.
- Adaptive RT holds the potential to improve overall survival rates in lung cancer patients.
